The head of the Africa Centres for Disease Control and Prevention (Africa CDC) announced on Thursday that a vaccine targeting the Bundibugyo strain of the Ebola virus is expected to be available by the end of 2026. This strain has been responsible for significant outbreaks, particularly in the Democratic Republic of Congo, where it has posed a serious public health challenge. Currently, there are no approved vaccines for this specific strain, highlighting the urgency and importance of the forthcoming development. The announcement underscores ongoing efforts to enhance disease prevention and control measures across the continent.
Related Articles
Don't miss out on breaking stories and in-depth articles.